Trials / Unknown
UnknownNCT03631134
Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin
Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The change of glycemic variation and insulin dose after adding SGLT2 inhibitor in type 2 diabetic patients treated with basal insulin was observed in a single center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SGLT2 inhibitor | Patients will be gave SGLT2 inhibitor 10mg per day |
Timeline
- Start date
- 2018-08-15
- Primary completion
- 2019-01-15
- Completion
- 2019-01-30
- First posted
- 2018-08-15
- Last updated
- 2018-08-15
Source: ClinicalTrials.gov record NCT03631134. Inclusion in this directory is not an endorsement.